Share chart Bristol-Myers
Extended chart
Simple chart
About Bristol-Myers
Компания Bristol-Myers Squibb обнаруживает, разрабатывает, лицензирует, производит и продает биофармацевтические продукты по всему миру. Компания предлагает продукцию в терапевтических классах гематологии, онкологии, сердечно-сосудистой системы и иммунологии. more detailsMain settings
IPO date
1972-01-01
ISIN
US1101221083
Industry
Pharmaceuticals
Sector
Health Care
Валюта
usd
Валюта отчета
usd
Див.доход ао
4.06
Дивиденд ао
0.62
Сайт
Grade
Underestimation
| Title | Value | Grade |
| P/S | 2.35 | 6 |
| P/BV | 6.93 | 1 |
| P/E | 13.54 | 8 |
Efficiency
| Title | Value | Grade |
| ROA | -9.53 | 0 |
| ROE | -39.1 | 0 |
| ROIC | 9.09 | 3 |
Dividends
| Title | Value | Grade |
| Dividend yield | 4.61 | 10 |
| DSI | 0.9286 | 9.29 |
| Average dividend growth | 7.02 | 10 |
Debt
| Title | Value | Grade |
| Debt/EBITDA | 16.16 | 0 |
| Debt/Ratio | 0.5529 | 9 |
| Debt/Equity | 3.13 | 4 |
Growth impulse
| Title | Value | Grade |
| Yield Revenue, % | 13.59 | 2 |
| Yield Ebitda, % | -78.62 | 0 |
| Yield EPS, % | 10.91 | 2 |
Dividends
Prices
| Price | Min. | Max. | Change | Changes in the industry | Changes in the index | |
| Yesterday | 50.16 $ | 0 $ | 0 $ | 1.06 % | 0 % | 0 % |
| Week | 48.41 $ | 48.41 $ | 50.69 $ | 4.71 % | 0 % | 0 % |
| Month | 47.03 $ | 46.75 $ | 50.69 $ | 7.78 % | 0 % | 0 % |
| Three month | 53.74 $ | 44.12 $ | 61.07 $ | -5.68 % | 0 % | 0 % |
| Half a year | 59.12 $ | 44.12 $ | 63.11 $ | -14.26 % | 0 % | 0 % |
| Year | 48.24 $ | 39.66 $ | 63.11 $ | 5.08 % | 0 % | 0 % |
| 3 years | 68.53 $ | 39.66 $ | 81.04 $ | -26.03 % | 0 % | 0 % |
| 5 years | 62.62 $ | 39.66 $ | 81.04 $ | -19.05 % | 0 % | 0 % |
| 10 years | 56.03 $ | 39.66 $ | 81.04 $ | -9.53 % | 0 % | 0 % |
| Year to date | 53.9 $ | 44.12 $ | 63.11 $ | -5.96 % | 0 % | 0 % |
Main owners
Contained in ETF
| ETF | Share, % | Profitability for 1 year, % | Commission, % |
| iShares Evolved U.S. Innovative Healthcare ETF | 5.33 | 0.000586 | 0.18 |
| John Hancock Multifactor Healthcare ETF | 3.07 | 29.34 | 0.40 |
| Global X Longevity Thematic ETF | 2.56 | -2.24 | 0.50 |
| AVDR U.S. LargeCap ESG ETF | 2.42 | 0 | 0.60 |
| US Equity Dividend Select ETF | 2.02849 | -17.86 | 0.50 |
| Donoghue Forlines Innovation ETF | 1.84178 | 18.15 | 0.69 |
| UVA Dividend Value ETF | 1.65 | 0 | 0.80 |
| IQ Engender Equality ETF | 1.43909 | 7.62 | 0.45 |
| FCF US Quality ETF | 1.43627 | 9.78 | 0.59 |
| Fidelity New Millennium ETF | 1.31841 | -6.7 | 0.38 |
| Pacer Salt Low truBeta US Market ETF | 1.16 | 20.77 | 0.60 |
| iShares Morningstar Large-Cap Value ETF | 0.38783 | 53.47 | 0.25 |
| iShares Morningstar Large-Cap ETF | 0.2001 | 184.21 | 0.03 |
| Columbia U.S. ESG Equity Income ETF | 0.17609 | -3.6 | 0.35 |
| JPMorgan Corporate Bond Research Enhanced ETF | 0.07 | 1.94 | 0.09 |
| 1.67 | 19.66 | 0.43 |
|---|
Similar companies
P/E & P/BV
Company management
| Head | Job title | Payment | Year of birth |
| Mr. Timothy Power | VP & Head of Investor Relations | N/A | |
| Mr. Greg Meyers | Executive VP and Chief Digital & Technology Officer | N/A | 1973 (52 years) |
| Ms. Kimberly M. Jablonski | Chief Compliance & Ethics Officer | N/A | |
| Ms. Ahn Amanda Poole | Executive Vice President & Chief Human Resources Officer | N/A | 1975 (50 years) |
| Dr. Christopher S. Boerner Ph.D. | CEO & Chairman | 1971 (54 years) | |
| Mr. David V. Elkins | Executive VP & CFO | 1968 (57 years) | |
| Ms. Sandra Leung Esq. | Executive VP & General Counsel | 1961 (64 years) | |
| Mr. Samit Hirawat M.D. | Executive VP, Chief Medical Officer & Head of Development | 1969 (56 years) | |
| Dr. Joseph J. Eiden Jr. | Head of Medical Affairs | 1949 (76 years) | |
| Mr. Adam Lenkowsky | Executive VP, Chief Commercialization Officer & Head of U.S. Oncology | 1972 (53 years) |
About company
Address: United States, New York, 430 East 29th Street - Open in google maps, Open in yandex maps
Website: http://www.bms.com
Website: http://www.bms.com
